CMH Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-28,049
Closed -$2.43M 45
2023
Q2
$2.43M Buy
28,049
+964
+4% +$83.6K 0.65% 43
2023
Q1
$2.63M Sell
27,085
-14,884
-35% -$1.45M 0.76% 43
2022
Q4
$4.34M Sell
41,969
-215
-0.5% -$22.3K 1.39% 33
2022
Q3
$3.58M Sell
42,184
-967
-2% -$82K 1.31% 34
2022
Q2
$3.58M Buy
43,151
+1,664
+4% +$138K 1.29% 31
2022
Q1
$3.2M Buy
41,487
+3,911
+10% +$302K 0.98% 39
2021
Q4
$3.32M Sell
37,576
-85
-0.2% -$7.51K 1% 39
2021
Q3
$2.91M Buy
37,661
+1,735
+5% +$134K 0.96% 38
2021
Q2
$3M Buy
35,926
+1,934
+6% +$161K 1% 37
2021
Q1
$2.57M Buy
33,992
+879
+3% +$66.4K 0.97% 38
2020
Q4
$2.9M Buy
33,113
+7,906
+31% +$693K 1.06% 35
2020
Q3
$1.92M Buy
25,207
+3,751
+17% +$285K 0.82% 39
2020
Q2
$2.65M Sell
21,456
-1,619
-7% -$200K 1.26% 32
2020
Q1
$1.95M Buy
23,075
+1,295
+6% +$109K 1.14% 42
2019
Q4
$1.84M Sell
21,780
-21,930
-50% -$1.85M 0.95% 45
2019
Q3
$2.95M Buy
43,710
+16,342
+60% +$1.1M 1.67% 24
2019
Q2
$2.34M Buy
27,368
+85
+0.3% +$7.28K 1.38% 33
2019
Q1
$2.42M Buy
27,283
+14,010
+106% +$1.24M 1.47% 28
2018
Q4
$1.13M Buy
13,273
+50
+0.4% +$4.26K 0.68% 52
2018
Q3
$1.3M Buy
13,223
+1,585
+14% +$156K 0.68% 51
2018
Q2
$1.09M Sell
11,638
-25
-0.2% -$2.35K 0.63% 50
2018
Q1
$901K Sell
11,663
-9,775
-46% -$755K 0.61% 48
2017
Q4
$1.95M Sell
21,438
-45
-0.2% -$4.1K 1.29% 29
2017
Q3
$2.01M Sell
21,483
-165
-0.8% -$15.5K 1.49% 24
2017
Q2
$1.99M Sell
21,648
-155
-0.7% -$14.2K 1.59% 24
2017
Q1
$1.93M Sell
21,803
-302
-1% -$26.7K 1.51% 26
2016
Q4
$1.89M Buy
+22,105
New +$1.89M 1.65% 21